AstraZeneca

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.

About AZN

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology.

CEO

Pascal Soriot

CEOPascal Soriot

Employees

96,100

Employees96,100

Headquarters

Cambridge, Cambridgeshire

HeadquartersCambridge, Cambridgeshire

Founded

1913

Founded1913

Employees

96,100

Employees96,100

AZN Key Statistics

Market cap

316.36B

Market cap316.36B

Price-Earnings ratio

30.93

Price-Earnings ratio30.93

Dividend yield

1.54%

Dividend yield1.54%

Average volume

2.09M

Average volume2.09M

High today

$207.44

High today$207.44

Low today

$203.82

Low today$203.82

Open price

$207.29

Open price$207.29

Volume

1.56M

Volume1.56M

52 Week high

$212.71

52 Week high$212.71

52 Week low

$128.89

52 Week low$128.89

Stock Snapshot

AstraZeneca(AZN) stock is priced at $204.03, giving the company a market capitalization of 316.36B. It carries a P/E multiple of 30.93 and pays a dividend yield of 1.5%.

On 2026-04-12, AstraZeneca(AZN) stock traded between a low of $203.82 and a high of $207.44. Shares are currently priced at $204.03, which is +0.1% above the low and -1.6% below the high.

AstraZeneca(AZN) shares are trading with a volume of 1.56M, against a daily average of 2.09M.

During the past year, AstraZeneca(AZN) stock moved between $128.89 at its lowest and $212.71 at its peak.

AZN News

TipRanks 3d

AstraZeneca Wins Strong Shareholder Backing at 2026 AGM

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

TipRanks 4d

AstraZeneca Extends Fasenra’s Runway With New Long-Term Safety Study

AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper de...

TipRanks 4d

ESPERANZA Update: Real-World Data Study Could Broaden AstraZeneca’s T-DXd Cancer Opportunity

AstraZeneca ($~AZN) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisio...

Analyst ratings

81%

of 31 ratings

Buy

80.6%

Hold

9.7%

Sell

9.7%

More AZN News

TipRanks 5d

AstraZeneca: Oncology and CVRM Momentum, Pipeline Progress, and FX Tailwinds Underpin Raised £165 Price Target and Buy Rating

In a report released today, Sarita Kapila from Morgan Stanley reiterated a Buy rating on AstraZeneca, with a price target of p16,500.00. Unlock hedge fund-leve...

People also own

Based on the portfolios of people who own AZN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.